Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Published in: Current HIV/AIDS Reports 1/2013

01-03-2013 | The Science of Prevention (S Kalichman, Section Editor)

State of Condom Use in HIV Prevention Science and Practice

Author: Richard A. Crosby

Published in: Current HIV/AIDS Reports | Issue 1/2013

Login to get access

Abstract

Condom use remains as the frontline defense against the HIV/AIDS pandemic. Fortunately, an ever-expanding body of empirical literature is currently guiding improvements in use of this prevention strategy. Recent advances include improved measurement of condom use behaviors, advances in condom effectiveness research, innovations in the design of condoms, and greater intervention efficiency for high-risk populations. After reviewing each of these four areas of research, this article will offer speculation about the future of condom use for HIV prevention.
Literature
1.
2.
Padian NS, McCoy SI, Karim SSA, et al. HIV prevention transformed: the new prevention research agenda. Lancet. 2011;378:269–78.PubMedCrossRef
3.
Cohen MS, Baden LR. Pre-exposure prophylaxis for HIV – where do we go from here? N Engl J Med. 2012;367:459–61.PubMedCrossRef
4.
Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.PubMedCrossRef
5.
Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;267:399–410.CrossRef
6.
Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral pre-exposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.PubMedCrossRef
7.
8.
Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission (Review). Cochrane Database Syst Rev. 2002;Issue 1. Art. No.:CD003255.
9.
Curran JW, Crosby RA. Pre-exposure Prophylaxis (PrEP): who will benefit and what are the challenges? Am J Prev Med. (in press).
10.
Reducing Misclassification Bias in Sex Research Through the use of Personal Digital Assistants. Third Youth Annual Conference on Youth and Technology & Sexual Health. San Francisco, CA, 26–27 February 2010.
11.
Graham CA, Crosby RA, Sanders SA, Yarber WL. Assessment of condom use in men and women. Annu Rev Sex Res. 2006;16:2–52.
12.
Crosby RA, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytic considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect. 2002;78:228–31.PubMedCrossRef
13.
Warner L, Newman DR, Fishbein M, et al. Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia. Am J Epidemiol. 2008;167:341–9.PubMedCrossRef
14.
Crosby RA, Salazar LF, DiClemente RJ, et al. Accounting for failures may improve precision: evidence supporting improved validity of self-reported condom use. Sex Transm Dis. 2005;32:513–5.PubMedCrossRef
15.
Crosby RA, DiClemente RJ, Yarber WL, et al. An event-specific analysis of condom breakage among African American men at risk of HIV acquisition. Sex Transm Dis. 2008;35:174–8.PubMedCrossRef
16.
17.
•• Crosby RA, Bounse S. Condom effectiveness: where are we now? Sex Health. 2012;9:10–7. This is a review of methodological issues and selected studies that pertain to the evaluation of condom effectiveness against sexually transmitted diseases. Practical guidance is provided for future research efforts aimed at determining condom effectiveness. PubMedCrossRef
18.
Crosby RA, Yarber WL, Sanders SA, Graham CA. Condom use as a dependent variable: a brief commentary about classification of inconsistent users. AIDS Behav. 2004;8:99–103.PubMedCrossRef
19.
•• Crosby RA, Charnigo R, Weathers C, et al. Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect. 2012;88:484–8. doi:10.​1136/​sextrans-2012-050618. This is the first NIH-funded study designed specifically to test condom effectiveness against non-viral sexually transmitted infections. The findings clearly illustrate that condom effectiveness is dependent on correct use.
20.
•• Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RM. Condom use errors and problems: a global view. Sex Health. 2012;9:81–5. This review paper reports findings on condom use errors and problems in fourteen countries. The findings make a very clear case that condom use errors and condom use problems are ubiquitous globally. PubMedCrossRef
21.
22.
• Crosby RA, Yarber WL, Graham CA, Sanders SA. Does it fit okay? Problems with condom use as a function of self-reported poor fit. Sex Transm Infect. 2010;86:36–8. doi:10.​1136/​sti.​2009.​036665. This study provides novel evidence suggesting that ill-fitting condoms are highly problematic for men and imying that public health programs should make condoms available in a full range of sizes. PubMedCrossRef
23.
Crosby RA, Milhausen R, Yarber WL, Sanders SA, Graham CA. Condom “Turn Offs” among adults: an exploratory study. Int J STD AIDS. 2008;19:590–4.PubMedCrossRef
24.
Reece M, Dodge B, Herbenick D, et al. Experiences of condom fit and feel among African American men who have sex with men. Sex Transm Dis. 2007;83:454–7.CrossRef
25.
Reece M, Herbenick D, Sanders SA, et al. Breakage, slippage and acceptability outcomes of a condom fitted to penile dimensions. Sex Transm Infect. 2008;84:143–9.PubMedCrossRef
26.
Crosby RA, Graham CA, Yarber WL, Sanders SA. If the condom fits, wear it: a qualitative study of young African American men. Sex Transm Infect. 2004;80:306–9.PubMedCrossRef
27.
Cecil M, Nelson AL, Trussell J, Hatcher R. If the condom does not fit, you must resize it. Contraception. 2010;82:489–90.PubMedCrossRef
28.
• Graham CA, Crosby RA, Milhausen RR, Sanders SA, Yarber WL. Incomplete use of condoms: the importance of sexual arousal. AIDS Behav. 2011;15:1328–31. This study provides sound evidence suggesting that delayed application of condoms and early removal are each related to condom associated erection problems. PubMedCrossRef
29.
Crosby RA, Graham CA, Yarber WL, Sanders SA. Problems with condoms may be reduced for men taking ample time to apply them. Sex Health. 2010;7:66–70.PubMedCrossRef
30.
Sanders SA, Milhausen RM, Crosby RA, Graham CG, Yarber WL. Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage? J Sex Med. 2009;6:1451–6.PubMedCrossRef
31.
•• Crosby RA, DiClemente RJ, Charnigo R, et al. A brief, clinic-based, safer sex intervention for African American men at-risk of HIV acquisition: a randomized controlled trial. Am J Public Health. 2009;99:S96–S103. The randomized controlled trial established the efficacy of a brief, clinic-based, condom use promotion program for young Black men attending STD clinics. The effect size of this one hour, face-to-face, intervention program was significant and substantial. PubMedCrossRef
32.
Jones KT, Gray P, Whiteside YO, et al. Evaluation of an HIV prevention intervention adapted for Black men who have sex with men. Am J Public Health. 2008;98:1043–50.PubMedCrossRef
33.
Beksinska M, Smit JA, Mantell JE. Progress and challenges to male and female condom use in South Africa. Sex Health. 2012;9:51–8.PubMedCrossRef
34.
Shisana O, Rehle T, Simbayi LC, Zuma K, Josste S, Pillay-van-Wyk V, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers? Cape Town: HSRC; 2009.
35.
Human Sciences Research Council (HSRC). South African National HIV Prevalence, HIV Incidence, Behaviour Change and Communications Survey, 2002. Cape Town: HSRC; 2002.
36.
Shisana O, Rehle T, Simbayi L, Parker W, Bhana A, Zuma K, et al. South African national HIV Prevalence, Incidence, Behaviour and Communications Survey, 2005. Cape Town: HSRC; 2005.
37.
38.
Matika-Tyndale E. Condoms in Sub-Sahara Africa. Sex Health. 2012;9:59–72.CrossRef
39.
Gallo MF, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health. 2012;9:18–26.PubMedCrossRef
40.
Kelvin E, Mantell JE, Candelario N, Hoffman S, Exner TM, Stackhouse W, et al. Off-label use of the female condom for anal intercourse among men in New York City. Am J Public Health. 2011;101:2241–4.PubMedCrossRef
41.
42.
Crosby RA, Ricks J, Young A. Condom migration resulting from circumcision, microbicides, and vaccines: brief review and methodological considerations. Sex Health. 2012;9:96–102.PubMedCrossRef
43.
Allman D, Xu K, Aguinaldo J, et al. Delayed application of condoms with safe and unsafe sex: factors associated with HIV risk in a community sample of gay and bisexual men. AIDS Care. 2009;21:775–84.PubMedCrossRef
44.
Warner L, Gallo MF, Macaluso M. Condom use around the globe: how can we fulfill the prevention potential of male condoms? Sex Health. 2012;9:4–9.PubMedCrossRef
45.
Sanders SA, Reece M, Herbenick D, et al. Condom use during most recent vaginal sexual intercourse event among a probability sample of adults in the United States. J Sex Med. 2010;7:362–73.PubMedCrossRef
Metadata
Title
State of Condom Use in HIV Prevention Science and Practice
Author
Richard A. Crosby
Publication date
01-03-2013
Publisher
Current Science Inc.
Published in
Current HIV/AIDS Reports / Issue 1/2013
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-012-0143-7

Other articles of this Issue 1/2013

Current HIV/AIDS Reports 1/2013 Go to the issue

HIV Pathogenesis and Treatment (A Landay, Section Editor)

Attacking the HIV Reservoir from the Immune and Viral Perspective

Invited Commentary

HIV: So Near and Yet So Far

HIV Pathogenesis and Treatment (A Landay, Section Editor)

Immunity and Hepatitis C: A Review

HIV Pathogenesis and Treatment (A Landay, Section Editor)

Revising the Role of Myeloid cells in HIV Pathogenesis

The Science of Prevention (S Kalichman, Section Editor)

HIV/STI Risk Among Venue-Based Female Sex Workers Across the Globe: A Look Back and the Way Forward

HIV Pathogenesis and Treatment (A Landay, Section Editor)

Pathogenesis of HIV and the Lung
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits